medetomidine has been researched along with Cirrhosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gilsbach, R; Hein, L; Leemhuis, J; Lother, A; Schickinger, S; Schneider, J | 1 |
1 other study(ies) available for medetomidine and Cirrhosis
Article | Year |
---|---|
Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Endocytosis; Feedback, Physiological; Fibrosis; Gene Expression Profiling; Heart; Heart Rate; Humans; Hypertension; Medetomidine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardium; Neurites; Norepinephrine; Promoter Regions, Genetic; Receptors, Adrenergic, alpha-2; RNA, Messenger; Sympathetic Fibers, Postganglionic; Sympathetic Nervous System | 2010 |